The Trust Board oversees the work of the organisation and is legally responsible for setting our strategic direction in line with national policy, and ensuring that its duties and obligations are carried out effectively.

The Board meets at least bimonthly. Members of the public can attend meetings virtually and submit questions in advance of meetings. 

To read the agenda and supporting papers for meetings, or to find out more about attending or asking a question, visit this page about board meetings.

The Board comprises a chair, six non-executive directors and six executive directors – including the chief executive. Two non-voting directors also attend.


Kathy Doran

Kathy Doran

Kathy joined the Trust as Chair in 2019 and brings over 40 years of public sector experience at national, local and regional levels.

From 2006-11, Kathy was chief executive of Wirral Primary Care Trust (PCT). She then spent two years as chief executive of Cheshire, Warrington and Wirral PCT Cluster from 2011-13.

In addition to having an in-depth understanding of the NHS, Kathy has a significant amount of leadership and board experience, having held non-executive and chairing roles in the NHS, housing and the third sector.

Executive directors

 Liz Bishop, Chief Executive


Dr Liz Bishop has been Chief Executive of The Clatterbridge Cancer Centre and Senior Responsible Officer (SRO) for Cheshire & Merseyside Cancer Alliance since 2018. She is also the Diagnostics Lead for Cheshire & Merseyside and chairs the North West Radiotherapy Operational Delivery Network.

Liz specialised in cancer nursing and, driven by a desire to improve the experiences and outcomes of people with cancer, moved into management, holding senior roles in London teaching hospitals for many years. She was Head of Nursing and General Manager at Guy’s and St Thomas’ and Deputy Chief Executive at The Royal Marsden before joining Clatterbridge.

She was attracted to Clatterbridge by the once-in-a-lifetime opportunity to deliver change that would bring enormous benefits to cancer patients with the opening of a new flagship oncology hospital in Liverpool, located next to a major acute hospital and university.

Liz is also deeply committed to working in partnership with other organisations to deliver the best for people with cancer at all stages of their journey. As SRO for Cheshire & Merseyside Cancer Alliance, she plays a leading role in overseeing the whole cancer ‘pathway’ within the region including screening diagnosis, surgery, systemic anti-cancer therapy (e.g. chemotherapy and immunotherapy), radiotherapy, clinical therapies, palliative care, and wraparound services that support people living with and beyond cancer.

In February 2024 Liz was appointed Chief Executive of Liverpool Heart and Chest Hospital whilst continuing as Chief Executive of The Clatterbridge Cancer Centre. Both trusts operate as separate statutory organisations with a shared CEO.

 Joan Spencer, Chief Operating Officer and Deputy Chief Executive

Joan was appointed Chief Operating Officer at Clatterbridge in 2020. She originally joined the Trust in 2014 as General Manager of Chemotherapy, before becoming a member of the executive team as Interim Director of Operations in 2019.

In addition to her duties as Chief Operating Officer, Joan was appointed Deputy Chief Executive in February 2024.

A cancer nurse by background, Joan worked at the Royal Liverpool University Hospital in various roles, including Lead Nurse for Breast Services (1997-2010), Associate Directorate Manager (2010-11) and Directorate Manager for Surgical Services (2011-14).

 Sheena Khanduri, Medical Director

Dr Khanduri was appointed Medical Director at The Clatterbridge Cancer Centre in 2017. In addition to being Medical Director, Sheena continues to practise as a consultant clinical oncologist, specialising in breast cancer.

Originally from Birmingham, Sheena studied medicine at the University of Cambridge and trained in clinical oncology in the West Midland and Yorkshire Deaneries.

In 2007 she was appointed as a consultant at Shrewsbury and Telford Hospitals in Shropshire, where she was successively radiotherapy lead and departmental lead before becoming lead clinician for cancer services in 2016. She also served on the Heads of Service Committee for the Royal College of Radiologists.

Sheena has a postgraduate qualification in strategic leadership from the University of Warwick and completed the Strategic Clinical Leaders Programme with The King’s Fund in 2019.

Dr Khanduri is the Trust's Responsible Officer, Caldicott Guardian and Executive Lead for Research.

 Julie Gray, Chief Nurse

Julie joined The Clatterbridge Cancer Centre as Chief Nurse in 2021. She joined us from The Christie in Manchester, where she was Director of Nursing and Director of Infection Prevention and Control.

Julie qualified as a nurse in 1993 after training in Salford and at the Bolton School of Nursing and Midwifery, spending the first years of her career as a staff nurse in gastroenterology, intensive care, adult medicine and general surgery.

After working as a clinical tutor for a number of years, Julie joined The Christie in 2005 as a specialist nurse in blood transfusion and moved into more senior roles there as a nursing manager and then director. 

Julie has a strong interest in nurse education and professional development, and in transformation and continually improving quality of care. She has a longstanding commitment to improving the quality of care and experience of people with cancer.

 Jayne Shaw, Director of Workforce and Organisational Development


Jayne joined the Trust as Director of Workforce and Organisational Development in 2018, having held similar executive roles in the NHS for 15 years. She has worked for organisations specialising in different aspects of healthcare, including mental health and acute services. 

Jayne has significant experience of successful workforce development and organisational change, to improve patient care and staff performance.

 James Thomson, Director of Finance

James joined the Trust as Director of Finance in 2019, having previously been Deputy Director of Finance at The Christie in Manchester. Prior to this, he held a number of senior finance positions in the healthcare sector.

James has a strong focus on financial delivery, commercial development and is committed to supporting excellent patient care through sustainable financial planning and decision making.

James is the executive director representative for our subsidiary companies.

In February 2024 James was appointed Director of Finance at Liverpool Heart and Chest Hospital whilst continuing in the same role at The Clatterbridge Cancer Centre. Both trusts remain separate statutory organisations.

 Sarah Barr, Chief Information Officer

Non-voting director

Sarah joined the Trust as Chief Information Officer in 2017 and the Board as a non-voting member in 2019. 

Sarah has a degree in public management and a postgraduate diploma in health informatics. She achieved an Executive Healthcare Leadership award through the Nye Bevan Programme in 2019. 

Sarah has over 24 years’ experience working in digital and informatics and was previously Deputy Director of Informatics at Mersey Care NHS Foundation Trust.

 Tom Pharaoh, Director of Strategy

Non-voting director

Tom joined Clatterbridge in 2019 having held various NHS management roles in the North West since moving to Liverpool from London, including at The Christie and as a general manager in the Royal Liverpool University Hospital. 

Tom joined the Board as a non-voting member in 2020 and provides specialist knowledge, advice and insight into key strategic decisions. He is also our executive lead for sustainability and our green plan.

In April 2024 Tom was appointed Director of Strategy at Liverpool Heart and Chest Hospital whilst continuing in the same role at The Clatterbridge Cancer Centre. Both trusts remain separate statutory organisations.

Non-executive directors

 Mark Tattersall, Vice Chair

Mark joined the Board in 2018 and brings with him significant experience as both an executive and non-executive director across the NHS, private and public sectors.

He has been Vice Chair of the Trust Board since 2021.

 Geoff Broadhead, Senior Independent Director

Geoff initially joined the Board as an associate non-executive director in 2018 and has been a full non-executive director since 2019. He has been the Senior Independent Director since January 2021.

Geoff has over 30 years’ experience in senior financial roles within the public and private sectors, including more than 20 years at board level. He has significant experience in corporate services, having managed finance, IT, human resources and facilities services. 

Geoff is Chair of our pharmacy subsidiary, PharmaC, and non-executive lead for Freedom to Speak Up at the Trust.

 Elkan Abrahamson

Elkan joined the Board in 2019. He qualified as a solicitor in 1983, working in Hong Kong and latterly in the United Kingdom, specialising in child care law and prisoners’ rights.

Elkan has significant board-level experience in the private sector and is a trustee of the Bloom Appeal, a local charity founded to help patients with blood cancers.

 Terry Jones

Terry brings a wealth of clinical experience and research expertise to the Board and is currently the Professor of Head and Neck Surgery at the University of Liverpool and Director of the Liverpool Head and Neck Centre. 

In addition to his clinical role as a head and neck cancer surgeon, Terry has led the development and delivery of many clinical trials and is currently Director of Research and Innovation at Liverpool University Hospitals and Director of Research for the Cheshire and Merseyside Integrated Care System.

 Anna Rothery

Anna joined the Board in 2021. She was Lord Mayor of Liverpool from 2019 to 2021 and has an extensive and wide-ranging background in public service, with a particular focus on equality, business and community development initiatives.

Raised in Toxteth, Anna has represented the Princes Park ward of Liverpool as a councillor since 2006 and was the council’s Chair of Culture Tourism and Sport from 2010-13. She was the council’s first elected member to address the United Nations in Geneva on religious, cultural and linguistic differences.

Anna studied sociology, psychology and law and undertook a masters in business and regeneration in 2007 at the University of Liverpool.

Anna won the HSBC Ethnicity Award for a Political Figure in 2019 and the House of Lords Baton Award for most influential black female politician in the same year. She made history both by becoming Liverpool’s first black lord mayor and the first lord mayor in the city to be reappointed to the role – serving two terms.

 Asutosh Yagnik

Asutosh joined the Board in 2021. He began his career in pharmaceutical research and has an impressive track record as a strategic advisor, and in leadership and governance. 
Asutosh studying chemistry at the University of Exeter, he went on to gain a masters and doctorate in computational chemistry and rational drug design. In June 2009, he was awarded chartered scientist status by the UK Science Council.

After working as a research fellow, Asutosh moved into consultancy, where he advised global companies on strategy, transformation and supply chain. In 2003, he founded AdSidera, a leadership coaching and management consulting firm. He has been a member of organising committees for the Cura Foundation 2016, and 2018 Vatican Conferences on Regenerative Medicine.